In addition to reviewing and signing out cases across a broad next-generation sequencing (NGS) portfolio, the successful candidate will lead the launch, validation, and growth of a high-impact solid tumor minimal residual disease (MRD) assay, with end-to-end responsibility for medical quality, regulatory compliance, and clinical excellence across the laboratorys test menu. With 13 years of laboratory experience, we specialize in placing pathologists, pathologists assistants, histotechnicians/histotechnologists, cytologists, medical lab techs, medical lab scientists, and lab leaders in travel, permanent, and temp-to-perm laboratory positions nationwide.